Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, specifically targeting Pulmonary Hypertension resulting from Heart Failure with preserved Ejection Fraction (PH-HFpEF)
Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, specifically targeting Pulmonary Hypertension resulting from Heart Failure with preserved Ejection Fraction (PH-HFpEF).